Adaptive immune response – Page 11 – Communicable Diseases Research

Immune response variables and viral mutations impact on COVID-19 reinfection and relapse

Review

Published on 2021-09-082022-10-04
Journal: International immunopharmacology [Category] MERS, SARS, 변종, 유전자 메커니즘, 진단,

Quantifying T Cell Cross-Reactivity: Influenza and Coronaviruses

Review

Published on 2021-09-072022-10-28
Journal: Viruses [Category] COVID-19,

Role of neutrophils in acute viral infection

Review Article

Published on 2021-09-022022-10-30
Journal: Immunity, Inflammation and Disease [Category] COVID-19,

Profile of humoral and cellular immune responses to single doses of BNT162b2 or ChAdOx1 nCoV-19 vaccines in residents and staff within residential care homes (VIVALDI): an observational study

Observational Study

Published on 2021-09-012022-10-05
Journal: The Lancet. Healthy longevity [Category] SARS, 임상,

[키워드] ACE2 binding Adaptive immune response age All participant antibody Antibody Response Antibody titre antibody titres B.1.1.7 B.1.351 B.1.351 variant blood sample BNT162b2 Care Cellular immune response cellular response ChAdOx1 nCoV-19 ChAdOx1 nCoV-19 vaccine Cohort collected correlated correlation country Coverage COVID-19 COVID-19 mortality COVID-19 vaccination COVID-19 vaccine defined Department Evidence extended interval first dose history humoral IgG antibody immune responses immunoassay Impact independent Infection infection with SARS-CoV-2 Interaction IQR kinetic magnitude median median age of BNT162b2 Older P.1 variant P.1 variants participant Participants peptide positive pre-vaccination profile resident response SARS-COV-2 infection SARS-CoV-2 strain second dose serological evidence significantly lower single dose Spike protein spike-specific IgG T-cell Response tested titre vaccination Vaccine vaccine dose variant variants of SARS-CoV-2 were assessed were excluded
[DOI] 10.1016/S2666-7568(21)00168-9 PMC 바로가기 [Article Type] Observational Study

SARS-CoV-2 Serology Status Detected by Commercialized Platforms Distinguishes Previous Infection and Vaccination Adaptive Immune Responses

상용화된 플랫폼에 의해 감지된 SARS-CoV-2 혈청학 상태는 이전 감염 및 예방 접종 적응 면역 반응을 구별합니다

Article

Published on 2021-09-012022-09-11
Journal: The journal of applied laboratory medicine [Category] SARS, 진단, 치료기술, 치료법,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus-2 Adaptive immune response adaptive immune responses antibody booster Cohort commercial assays Coronavirus-2 correlated correlation COVID-19 death detect dose evaluated healthcare worker IgG immune response immune responses individual infected individuals Infection infective Infective dose initial median Moderna NAb NAbs natural infection neutralization titer neutralization titers Neutralizing Neutralizing antibodies neutralizing antibody Patient Pfizer platform positive pseudovirus PSV reactivity respiratory response Roche SARS-CoV-2 SARS-CoV-2 infected individuals SARS-CoV-2 NAb SARS-CoV-2 PCR SARS-CoV-2 pseudovirus serology Severe acute respiratory syndrome severe acute respiratory syndrome Coronavirus single dose status understanding utility vaccinated individual vaccinated individuals vaccination Vaccine Vaccines
[DOI] 10.1093/jalm/jfab080 PMC 바로가기 [Article Type] Article

Quantitation of antibodies against SARS-CoV-2 spike protein after two doses of CoronaVac in healthcare workers

의료 종사자에서 코로나백 2회 투여 후 SARS-CoV-2 스파이크 단백질에 대한 항체 정량

Article

Published on 2021-09-012022-09-12
Journal: Journal of medical virology [Category] 진단,

[키워드] Abbott acute respiratory syndrome Adaptive immune response age Anti-spike anti-Spike IgG antibody Antibody titer Chemiluminescent microparticle immunoassay chronic disease Chronic diseases CoronaVac coronavirus cutoff value detection dose facilitate female first dose Frequency greater group HCW HCWs healthcare healthcare worker Healthcare workers help highest Humoral immunity immunoassay indicated less male median men Microparticle performed positive produced quantitation recruited reported Result SARS-CoV-2 SARS-CoV-2 IgG SARS-CoV-2 spike protein second dose Seropositivity serum sample significantly significantly higher the antibody response the spike protein the vaccine Turkey university hospital vaccination was performed women
[DOI] 10.1002/jmv.27098 PMC 바로가기 [Article Type] Article

COVID-19 Immunobiology: Lessons Learned, New Questions Arise

Immunology

Published on 2021-08-262022-11-01
Journal: Frontiers in Immunology [Category] COVID-19, MERS, SARS,

An immunogenetic view of COVID-19

Articles

Published on 2021-08-252022-10-31
Journal: Genetics and Molecular Biology [Category] COVID-19,

Biomarkers and Immune Repertoire Metrics Identified by Peripheral Blood Transcriptomic Sequencing Reveal the Pathogenesis of COVID-19

말초 혈액 전사체 시퀀싱으로 식별된 바이오마커 및 면역 레퍼토리 메트릭은 COVID-19의 발병 원인을 밝힙니다

Immunology

Published on 2021-08-242022-09-11
Journal: Frontiers in Immunology [Category] MERS, SARS, 바이오마커, 유전자 메커니즘, 진단,

[키워드] acute infection acute phase acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Adaptive immune response alteration Analysis anti-SARS-CoV-2 anti-SARS-CoV-2 IgG B-cell response Biomarker Biomarkers caused change Clustering Cohort contribute convalescent convalescent patient coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 declined Effective vaccines facilitate feature FIVE gene expression profile Gene expression profiles help Host immune response Identified IgG immune immune responses increased expression independent Infection Inflammation machine learning Metrics molecular mechanism molecule nervous system pandemic Pathogenesis pathogenesis of COVID-19 Patient performed peripheral Peripheral blood positively correlated Post-infection predict Reinfection repertoire respiratory RNA sequencing SARS-CoV-2 SARS-COV-2 infection Serum level severe acute respiratory syndrome Coronavirus severe symptoms significantly T-cell T-cell Response therapeutic strategy transcriptomic characteristics UCHL1
[DOI] 10.3389/fimmu.2021.677025 PMC 바로가기 [Article Type] Immunology

Sargramostim (rhu GM-CSF) as Cancer Therapy (Systematic Review) and An Immunomodulator. A Drug Before Its Time?

Immunology

Published on 2021-08-172022-11-01
Journal: Frontiers in Immunology [Category] Coronavirus, MERS, SARS,

[키워드] accelerate accelerated acute respiratory distress Adaptive immune response adaptive immune system anti-cancer response approved ARDS Autoimmune biological activity Bone marrow bone marrow failure Cancer Clinical data clinical setting clinical settings COVID-19 database Diseases drug Efficacy ENhance Essential example FDA GM-CSF granulocyte-macrophage colony-stimulating factor hematologic host immunity humans immune Immune checkpoint inhibitor immune modulation Immune suppression immune therapy Immunotherapy Infection infections innate immune response less modulating monoclonal antibodies objective Other Pulmonary alveolar proteinosis reported Result resulting review safety profile sargramostim Sepsis significantly solid cancer survival syndrome Therapies therapy tissue repair Toxicity trauma US FDA Vaccine variety
[DOI] 10.3389/fimmu.2021.706186 PMC 바로가기 [Article Type] Immunology